Showing results (241-250 of 250) with videos related to
Sort By:
Pageof 25
You have reached the last page of results.This site can display upto 250 results.
Plant Molecular Biology|March 1, 1990
Inheritance and effect on ripening of antisense polygalacturonase genes in transgenic tomatoesC J Smith, C F Watson, P C Morris, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 30, 1998
A phase I and pharmacologic study of DMP 840 administered by 24-hour infusionS O'Reilly, S D Baker, S Sartorius, et al.Plant Molecular Biology|September 1, 1989
Control and manipulation of gene expression during tomato fruit ripeningW Schuch, C R Bird, J Ray, et al.Annals of Human Genetics|January 1, 1978
Segregation of ABO, AK1 and ACONs in families with abnormalities of chromosome 9P J Cook, E B Robson, K E Buckton, et al.Journal of Digital Imaging|August 1, 1997
Initial experience with soft-copy display of computed radiography images on three picture archive and communication systemsN J Hangiandreou, L J Cesar, M R Bruesewitz, et al.BMC Cancer|August 29, 2019
Patient preferences of chemotherapy treatment options and tolerance of chemotherapy side effects in advanced stage lung cancerK M Islam, T Anggondowati, P E Deviany, et al.British Journal of Cancer|October 8, 2014
A parallel-arm phase I trial of the humanised anti-IGF-1R antibody dalotuzumab in combination with the AKT inhibitor MK-2206, the mTOR inhibitor ridaforolimus, or the NOTCH inhibitor MK-0752, in patients with advanced solid tumoursI Brana, R Berger, T Golan, et al.Oncogene|October 20, 2015
Differential association of STK11 and TP53 with KRAS mutation-associated gene expression, proliferation and immune surveillance in lung adenocarcinomaM B Schabath, E A Welsh, W J Fulp, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 20, 2021
Sacituzumab govitecan, a Trop-2-directed antibody-drug conjugate, for patients with epithelial cancer: final safety and efficacy results from the phase I/II IMMU-132-01 basket trialA Bardia, W A Messersmith, E A Kio, et al.ESMO Open|January 24, 2026
Global advances and future directions in lung cancer care: expert consensus and strategic prioritiesM-L Meyer, S Peters, P A Jänne, et al.Pageof 25